Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huons CoXKRX:243070 -1.97%87 Interest Coverage is 22.01 as of Jun. 2026, which is 16% below its 10-year median of 26.21. GuruFocus rates XKRX:243070 with a GF Score™ of 87/100 and a GF Value™ of ₩31,317.35 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 685 Drug Manufacturers companies, Huons Co ranks worse than 59.85% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Huons Co's
Operating Income
for the
three
months ended in Jun. 2026 was ₩60,224 Mil. Huons Co's Interest Expense for the
three
months ended in Jun. 2026 was ₩-2,736 Mil.
Huons Co's interest coverage for the quarter that ended in Jun. 2026 was 22.01.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Huons Co's Interest Coverage or its related term are showing as below:
XKRX:243070'
s Interest Coverage Range Over the Past 10 Years
Min: 7.29 Med: 26.21 Max: 47.22
Current: 14.35
XKRX:243070's Interest Coverage is ranked worse than 59.85% of 685
companies
in the Drug Manufacturers industry
Industry Median: 13.91
vs XKRX:243070: 14.35
Huons Co (XKRX:243070) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Huons Co Interest Coverage Related Terms
Huons Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Huons Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Huons Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huons Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Huons Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Huons Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huons Co (XKRX:243070) has a Interest Coverage of 22.01 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Huons Co and its competitors. This is 16% below median its historical median of 26.21. Over the past decade, Huons Co's Interest Coverage has ranged from 7.29 to 47.22. According to the industry distribution chart, Huons Co ranks #410 out of 685 companies in the Drug Manufacturers industry, placing it in the top 59.9%.
Is Huons Co's Interest Coverage too high?
Huons Co's current Interest Coverage of 22.01 is 16% below median its 10-year median of 26.21. Over the past 10 years, this metric has ranged from a low of 7.29 to a high of 47.22. The Drug Manufacturers industry median Interest Coverage is 13.91. Huons Co's value of 22.01 is 58.2% above this industry median. Based on the distribution chart, Huons Co ranks #410 out of 685 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Huons Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Huons Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Huons Co ranks #410 out of 685 companies for Interest Coverage. This places Huons Co in the lower half of its industry. The industry median Interest Coverage is 13.91. Huons Co's value of 22.01 is 58.2% above this benchmark. Historically, Huons Co's own Interest Coverage has ranged from 7.29 to 47.22 over the past decade. While the company's 10-year median is 26.21 vs. the industry median of 13.91, Huons Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.91, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huons Co's current Interest Coverage of 22.01 is 58.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Huons Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huons Co's current Interest Coverage is 22.01, which is 16% below median its own 10-year median of 26.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huons Co stock overvalued right now?
Based on GuruFocus' analysis, Huons Co (XKRX:243070) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩31,317.35, compared to a current price of ₩24,900.00 — trading 20.5% below its estimated fair value. The current Interest Coverage is 22.01, which is 16% below median its 10-year median of 26.21 and 58.2% above the Drug Manufacturers industry median of 13.91. Huons Co's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Huons Co (XKRX:243070), the current Interest Coverage is 22.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huons Co (XKRX:243070) Overvalued in 2026?
Based on GuruFocus' analysis, Huons Co stock appears to be undervalued.
The current stock price of ₩24,900.00 is trading 20.5% below its estimated GF Value™ of ₩31,317.35.
GuruFocus considers Huons Co to be Modestly Undervalued.
Key valuation signals for XKRX:243070:
Interest Coverage: 22.01 (16% below median its 10-year median of 26.21)
GF Value™: ₩31,317.35 vs. price of ₩24,900.00 (20.5% below fair value)
Industry Position: 58.2% above the Drug Manufacturers median (#410 of 685)
No single metric tells the full story. See the XKRX:243070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huons Co Ltd is a Korean company. It is engaged in the manufacture and distribution of pharmaceutical products. The company produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermine, diet pills, and capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. It also produces ampoules, vials, cartridges, and caps for use of medicals, foods, and cosmetics.
87GF Score
Get the complete analysis for XKRX:243070
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:243070 has been successfully added to your 
